Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597922 · ClinicalTrials.gov registry record
Examining Heart Attacks in Young Women
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 2,985
- Enrollment target
NCT00597922: Completed study, sponsored by Yale University.
NCT00597922 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 2,985 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00597922 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 2,985 participants
- Enrollment target
Study Summary
Heart disease and heart attacks pose a serious health risk to young women, and women tend to experience less successful recoveries after a heart attack than men do. This study will examine various factors that may predispose women to heart attacks and to poor recovery after a heart attack. The differences between men and women in the medical care that they receive following a heart attack will also be studied.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,985 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-02 |
What the finished NCT00597922 record still lists
NCT00597922 is an observational study that tracks outcomes without assigning an intervention. Its 2,985 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00597922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00597922 about?
NCT00597922 is a clinical study titled "Examining Heart Attacks in Young Women". Heart disease and heart attacks pose a serious health risk to young women, and women tend to experience less successful recoveries after a heart attack than men do. This study will examine various factors that may predispose women to heart attacks and to poor recovery after a heart attack. The diffe...
What is the current status of trial NCT00597922?
This trial is currently completed. The enrollment target is 2,985 participants. The study started on 2007-09. Estimated completion is 2013-02.
Who is sponsoring clinical trial NCT00597922?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05297734 · 2,996 participants · NA
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- NCT03860883 · 2,998 participants · NA
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia